Evaluation of Nutrition and Metabolism in Breast Cancer Patients
NCT ID: NCT01542216
Last Updated: 2015-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2012-02-29
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multiple Risk Factor Intervention Trial in Breast Cancer Survivors
NCT06454864
Yoga Study in Breast Cancer Patients
NCT00476203
Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation
NCT01157767
Effects of Yoga in Breast Cancer Patients
NCT00508794
A Yoga and Wellness Program for Breast Cancer Survivors With Persistent Fatigue
NCT00727662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Yoga and Stretching Group
Patients undergo yoga and stretching exercises
Yoga and Stretching Group
Patients randomized to this arm will receive consultations on yoga and stretching exercises.
Nutrition and Exercise Group
Patients are provided with nutrition, cardiovascular exercise and strength exercise consultations
Nutrition and Exercise Group
Patients randomized to this arm will receive nutrition and exercise consultations. Exercise consultations will home- and institution-based.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutrition and Exercise Group
Patients randomized to this arm will receive nutrition and exercise consultations. Exercise consultations will home- and institution-based.
Yoga and Stretching Group
Patients randomized to this arm will receive consultations on yoga and stretching exercises.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recent diagnosis of breast cancer and up to 4 weeks following the first cycle of chemotherapy or up to the first 4 weeks of radiation therapy
* Clinical Stages I-IIIa
* Able to communicate freely in English
* Have sufficient cognitive ability to participate and provide informed consent
Exclusion Criteria
* Any known diagnosis of diabetes or HIV
* Pre-existing injuries or health conditions that prevents the patient's safe participation in exercise
* Any previous diagnosis of cancer within the last 5 years (other than carcinoma in situ)
* Fasting glucose \>7.0 mM at baseline of the study
* Pregnant individuals will be excluded from this study
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grand River Regional Cancer Centre
OTHER
University of Waterloo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marina Mourtzakis, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Waterloo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Waterloo
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-0463
Identifier Type: OTHER
Identifier Source: secondary_id
17215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.